Global Primary Immunodeficiency Diseases Market US$ 6.1 Billion by 2021
Primary immunodeficiency diseases or disorders (PIDD or PI) are caused as part of the body's immune system is missing or does not function normally, such that it is an inherited flaw in the immune system that increases the susceptibility to infections. Besides susceptibility to infections, PIDD may cause other health problems as well, including allergies, asthma, swollen joints, digestive tract problems, growth problems or an enlarged liver and spleen.
The global primary immunodeficiency diseases market report estimates the market size in US$ million for 2014-2021, and forecasts growth trends over a period of 2017-2021. The market for key market segments has been estimated based on epidemiology approach considering patient diagnosis rates, patient treatment rate (IVIG/SCIG), average cost of treatment by regions. The highlights of the report include global number of PID patients, by disease (including subclasses), global number of patient population for treatment or therapy, global number of PID patients, by 15 most commonly identified PIDs by region, and by country, and PID patient’s gender and age by global comparative analysis. The global primary immunodeficiency disease (PIDD or PID or PI) market is dominated by North America and Europe, collectively accounting for major share of the market in 2016. National PID registries worldwide, increasing healthcare expenditure and government support are the major factors driving the global primary immunodeficiency diseases market during the forecast period.
Browse Primary Immunodeficiency Diseases Market by Disease Type (Antibody Deficiency – Agammaglobulinaemia, Common Variable Immune Deficiency, IgG Subclass Deficiency, SIgAD; Cellular Immunodeficiency – Ataxia Telangiectasia, DiGeorge Syndrome, Hyper IgM Syndromes, Wiskott-Aldrich Syndrome; Innate Immune Disorders – Complement Deficiencies, and Hyper IgE Syndrome) and Test Type (Blood and Prenatal Testing), and Treatment Type (Immunoglobulin Replacement Therapy, Antibiotics Therapy, Stem Cell and Gene Therapy) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/primary-immunodeficiency-diseases-market/
The report also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, major products and services offered, and recent trends in strategic management. The major companies profiled in the report include Baxter nternational, Inc., Bio Products Laboratory, Biotest AG, CSL Behring LLC, Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, and others.
1. Disease Type
1.1. Antibody Deficiency
1.1.2. Common Variable Immune Deficiency
1.1.3. IgG Subclass Deficiency
1.1.4. Selective IgA Deficiency (SIgAD)
1.2. Cellular Immunodeficiency
1.2.1. Ataxia Telangiectasia
1.2.2. DiGeorge Syndrome
1.2.3. Hyper IgM Syndromes
1.2.4. Wiskott-Aldrich Syndrome
1.3. Innate Immune Disorder
1.3.1. Complement Deficiencies
1.3.2. Hyper IgE Syndrome
2. Test Type
2.1. Blood Testing
2.2. Prenatal Testing
3. Treatment Type
3.1. Immunoglobulin Replacement Therapy
3.2. Antibiotics Therapy
3.3. Stem cell and Gene Therapy
4. Geography (Region, Country)
4.1. North America (U.S., Canada)
4.2. Latin America (Brazil, Mexico, Rest of LA)
4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.4. Asia Pacific (Japan, China, India, Rest of APAC)
4.5. Rest of the World
5. Company Profiles
5.1. Baxter International, Inc.
5.2. Bio Products Laboratory
5.3. Biotest AG
5.4. CSL Behring LLC
5.5. Grifols S.A.
5.6. Kedrion S.p.A.
5.7. LFB S.A.
5.8. Octapharma AG
To request Table of Contents and Sample Pages of this report visit:
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Primary Immunodeficiency Diseases Market US$ 6.1 Billion by 2021 here
News-ID: 721095 • Views: 86
More Releases from iHealthcareAnalyst, Inc.
Global Blood Gas Monitoring Products Market Growing at CAGR of 6.2% to Reach $5. …
The global market for blood gas monitoring products is estimated to reach $5.5 billion by the end of 2025, expanding at a CAGR of 6.2% during the forecast period, supported by growing geriatric population, rising prevalence of chronic diseases, and technological advances. The global blood gas monitoring devices market research report provides market size (Revenue US$ Million 2017 to 2025), market share analysis, growth trends and forecast (CAGR%, 2019 to 2025).
Advances in Mobile Connectivity Services to Drive Telemedicine Technologies and …
According to a new market research report Telemedicine Technologies and Services Market 2015-2023 published by iHealthcareAnalyst, Inc., the global computer-aided detection market to reach US$ 73.2 Billion by 2023, expanding at a CAGR of 13.5% from 2018-2023. Visit the Global Telemedicine Technologies and Services Market Analysis and Forecast 2018-2023 report at https://www.ihealthcareanalyst.com/report/telemedicine-technologies-services-market/ The global telemedicine technologies and services market newly published (updated 2018) report estimates the market size (US$ million 2015-2023)
Global Internet Pharmacies Market to Cross US$ 100 Billion by 2023
The global internet pharmacies market is estimated to reach US$ 106 Billion by 2023, growing at a CAGR of 15.7% over the forecast period, driven by rising personal disposable income, lower prices, surge in internet penetration, stupendous growth of online retail market and a large number of online players entering the online healthcare product segment. The major players are in a race to increase their share in the industry by
Global Cerebrospinal Fluid Management Market to Reach 1.9 US$ billion by 2023 gr …
According to a new market research report (updated 2018) published by iHealthcareAnalyst, Inc., Cerebrospinal Fluid Management Market – Global CSF Products Analysis and Forecast 2018-2023, the global cerebrospinal fluid management market was valued at US$ 1,045 Million in 2013 and to reach US$ 1.9 billion by 2023, growing at a CAGR of 5.5% from 2018-2023. Visit the Global Cerebrospinal Fluid Management Market – Global Patient Solutions, System Strengthening and End Users
More Releases for PID
Global PID Motion Controllers Market Analysis & Forecast 2019- QY Research
PID Controller is a control loop feedback mechanism which calculates an error value as the difference between a setpoint and a measured process variable. PID Controller stands for stands for proportional–integral–derivative controller. PID controllers are majorly used for pressure controlling, temperature controlling, flow controlling and motion controlling. Continuous innovations in technology has led to the introduction of smart PID controllers and hybrid PID controllers. Both smart PID controllers and hybrid PID
PID Motion Controllers Market Size, Share, Development by 2023
New report published by Global Info Research which offers insights on the global PID Motion Controllers market. PID Controller is a control loop feedback mechanism which calculates an error value as the difference between a setpoint and a measured process variable. PID Controller stands for stands for proportional–integral–derivative controller. PID controllers are majorly used for pressure controlling, temperature controlling, flow controlling and motion controlling.
Photoionization Detection (PID) Sensors Sales Global Market Report 2018
Global Research and Development News -- . . "Global Photoionization Detection (PID) Sensors Sales Market Report 2018" with coming years Industries Trends, projections of Global Growth, Major key player and Case study, Review, Share, Size, Effect. ' ' -This report studies the global Photoionization Detection (PID) Sensors market status and forecast, categorizes the global Photoionization Detection (PID) Sensors market size (value & volume) by key players, type, application, and region. This report focuses
PID Controller Market Foreseen to Grow exponentially over 2017 - 2027
PID Controller Market: Introduction The increasing demand for calculating and eliminating an error in a program and offering an efficient process for achieving optimal control of our systems led to the introduction of PID Controllers. A PID controller is majorly adopted in industrial control systems. PID Controller is a control loop feedback mechanism which calculates an error value as the difference between a setpoint and a measured process variable. PID Controller stands
Primary Immune Deficiency (PID) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Primary Immune Deficiency (PID) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Primary Immune Deficiency (PID) - Pipeline Review, H2 2017, provides an overview of the Primary Immune Deficiency (PID) (Genetic Disorders) pipeline landscape. Primary immunodeficiency is defined as weaken immune system, allowing repeated infections and
Primary Immune Deficiency (PID) - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Primary Immune Deficiency (PID) - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Primary Immune Deficiency (PID) - Pipeline Review, H1 2017, provides an overview of the Primary Immune Deficiency (PID) (Genetic Disorders) pipeline landscape. Primary immunodeficiency is defined as weaken immune system, allowing repeated infections and